December 21, 2004
Increasing Orgasm and Decreasing Dyspareunia by a Manual Physical Therapy TechniqueTopics: Medicine
I know that I'm going to get some flak out of this post but please remember that this is actually a clinpharm/medical site that has a Middle East and international news flair, not the other way around. So with no other preliminary comments we'll go ahead with the post which is a serious one, after all. The intent here is not to lose my general audience (G-rating) but to provide helpful and clinically-useful information. This post is in response to a reader's request.
Article Summary. In MedGenMed Ob/Gyn & Women's Health - From Medscape General Medicine.
Relatively recent investigations have found the prevalence of female sexual dysfunction (approximately 40%) to surpass that of males (approximately 30%). Despite the higher prevalence, there have been few investigatory studies of female sexual problems and fewer available treatments than for comparable male conditions.
the publication of the "Report of the International Consensus
Development Conference on Female Sexual Dysfunction: Definitions and
Classifications" in 2000, research has advanced. The committee built
upon the existing frameworks (ie, the DSM-IV and ICD-10) and expanded
its classifications to include both psychogenic and physiologic causes
of arousal, desire, orgasm, and sexual pain disorders.
Thus, despite the fact that dyspareunia had long been considered to be
psychogenic, it is now included in "Sexual Pain Disorders" due to its
solid biological base (eg, connective tissue, hormonal, iatrogenic,
inflammatory, muscular, neurologic, and vascular causes).
(Sources and references at article link below)
Lawrence J. Wurn, LMT; Belinda F. Wurn, PT; C. Richard King, MD; Amanda S. Roscow, MPT; Eugenia S. Scharf, PhD; Jonathan J. Shuster, PhD
Context: Female sexual pain and dysfunction
Objective: To evaluate the effectiveness of a new site-specific, manual soft-tissue therapy in increasing orgasm and reducing dyspareunia (painful intercourse) in women with histories indicating abdominopelvic adhesion formation.
Design and Intervention: A total of 29
new patients presenting with infertility or abdominopelvic pain-related
problems, and also indicating sexual pain or dysfunction, received a
series of treatments (mean, 19.5 hours) designed to address
biomechanical dysfunction and restricted mobility due to adhesions
affecting the reproductive organs and adjacent structures.
Outcome Measures: Primary outcome measures were post-test vs pretest scores on: (1) the Female Sexual Function Index (FSFI) full scale, orgasm domain, and pain domain; and (2) 3 supplemental 10-point rating scales of sexual pain levels. Secondary outcome measures were post-test vs pretest scores in the other 4 FSFI domains (desire, arousal, lubrication, and satisfaction). The Wilcoxon signed-rank test was used for all statistical analyses.
Results: For the 23 patients available for follow-up, the paired FSFI post-test vs pretest scores were significant (P </= .003) on all measures. Of the 17 patients who completed the 3 sexual pain scales, the paired post-test vs pretest scores were significant (P </= .002)
Conclusions: Many cases of inhibited orgasm, dyspareunia, and other aspects of sexual dysfunction seem to be treatable by a distinctive, noninvasive manual therapy with no risks and few, if any, adverse effects. The therapy should be considered a new adjunct to existing gynecologic and medical treatments. Continue reading the article in Medscape General Medicine.(Registration Required).
Posted by Hyscience at December 21, 2004 7:25 PM
Articles Related to Medicine: